0 CHECKOUT

BioCryst Pharmaceuticals, Inc. - Product Pipeline Review - 2015

  • ID: 3293064
  • May 2015
  • 37 pages
  • Global Markets Direct
1 of 3

BioCryst Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Summary

This, ‘BioCryst Pharmaceuticals, Inc. - Product Pipeline Review - 2015’, provides an overview of the BioCryst Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of BioCryst Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes READ MORE >

Note: Product cover images may vary from those shown
2 of 3

List of Tables
List of Figures
BioCryst Pharmaceuticals, Inc. Snapshot
BioCryst Pharmaceuticals, Inc. Overview
Key Information
Key Facts
BioCryst Pharmaceuticals, Inc. - Research and Development Overview
Key Therapeutic Areas
BioCryst Pharmaceuticals, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
BioCryst Pharmaceuticals, Inc. - Pipeline Products Glance
BioCryst Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
BioCryst Pharmaceuticals, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
BioCryst Pharmaceuticals, Inc. - Drug Profiles
BCX-4161
Product Description
Mechanism of Action
R&D Progress
BCX-4430
Product Description
Mechanism of Action
R&D Progress
BCX-7353
Product Description
Mechanism of Action
R&D Progress
Small Molecule 2 to Inhibit Plasma Kallikrein for Hereditary Angioedema
Product Description
Mechanism of Action
R&D Progress
BCX-xxxx
Product Description
Mechanism of Action
R&D Progress
BioCryst Pharmaceuticals, Inc. - Pipeline Analysis
BioCryst Pharmaceuticals, Inc. - Pipeline Products by Target
BioCryst Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
BioCryst Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
BioCryst Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
BioCryst Pharmaceuticals, Inc. - Recent Pipeline Updates
BioCryst Pharmaceuticals, Inc. - Dormant Projects
BioCryst Pharmaceuticals, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
BCX-5191
peldesine
BioCryst Pharmaceuticals, Inc. - Company Statement
BioCryst Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
BioCryst Pharmaceuticals, Inc., Key Information
BioCryst Pharmaceuticals, Inc., Key Facts
BioCryst Pharmaceuticals, Inc. - Pipeline by Indication, 2015
BioCryst Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
BioCryst Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
BioCryst Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2015
BioCryst Pharmaceuticals, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015
BioCryst Pharmaceuticals, Inc. - Phase II, 2015
BioCryst Pharmaceuticals, Inc. - Phase I, 2015
BioCryst Pharmaceuticals, Inc. - Preclinical, 2015
BioCryst Pharmaceuticals, Inc. - Discovery, 2015
BioCryst Pharmaceuticals, Inc. - Pipeline by Target, 2015
BioCryst Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015
BioCryst Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015
BioCryst Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015
BioCryst Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015
BioCryst Pharmaceuticals, Inc. - Dormant Developmental Projects,2015
BioCryst Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2015
BioCryst Pharmaceuticals, Inc., Other Locations
BioCryst Pharmaceuticals, Inc., Subsidiaries

List of Figures
BioCryst Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015
BioCryst Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
BioCryst Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
BioCryst Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015
BioCryst Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015
BioCryst Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015
BioCryst Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.